The most important financial indicators for the company Flowrond Med Srl - Unique Identification Number 36936376:
sales in 2023 was
877.409
euro, registering a net profit of
180.039
euro and having an average number of
4
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al masinilor pentru industria textila si al masinilor de cusut si de tricotat having the NACE code 4664.
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
In the last year of activity, the sales increased by 89.8%, from 463.630 euro in the year 2022, to 877.409 euro in 2023.
The Net Profit increased by 75.536 euro, from 104.821 euro in 2022, to 180.039 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Flowrond Med Srl - CUI 36936376
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
-
10
35.056
45.677
50.573
99.181
151.504
140.774
Current Assets
-
-
-
67.142
131.045
283.113
622.922
694.223
768.402
1.017.333
Inventories
-
-
-
1.469
56.658
52.528
22.125
96.989
19.605
103.593
Receivables
-
-
-
15.631
57.770
39.354
165.352
37.768
173.225
255.597
Cash
-
-
-
50.042
16.617
191.231
435.445
559.466
575.571
658.143
Shareholders Funds
-
-
-
52.502
143.196
277.792
592.334
739.627
840.210
985.781
Social Capital
-
-
-
44
43
42
41
40
41
40
Debts
-
-
-
14.650
23.120
51.365
81.577
54.369
80.198
173.105
Income in Advance
-
-
-
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4664 - 4664"
CAEN Financial Year
4669
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.017.333 euro in 2023 which includes Inventories of
103.593 euro, Receivables of
255.597 euro and cash availability of
658.143 euro.
The company's Equity was valued at
985.781 euro, while total Liabilities amounted to
173.105 euro.
Equity increased by 148.118 euro, from 840.210 euro in 2022, to 985.781 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Flowrond Med Srl